Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Than Meets the Eye With Melatonin Labeling?
05/02/2023
In the latest installment of Talking Therapeutics, Dr Jennings shares new research into melatonin supplements which showed product labels were often inaccurate and did not reflect the actual quantities of melatonin included in each serving.
In the latest installment of Talking Therapeutics, Dr Jennings shares new research into melatonin supplements which showed product labels were often inaccurate and did not reflect the actual quantities of melatonin included in each serving.
In the latest installment of...
05/02/2023
Pharmacy Learning Network
Talking Therapeutics
Advancing Decongestive Strategies in Acute Heart Failure
04/25/2024
In this installment of Talking Therapeutics, Dr Jennings analyzes recent study findings determining efficacy of dapagliflozin in patients with acute heart failure.
In this installment of Talking Therapeutics, Dr Jennings analyzes recent study findings determining efficacy of dapagliflozin in patients with acute heart failure.
In this installment of Talking...
04/25/2024
Pharmacy Learning Network
Talking Therapeutics
How to Talk to Patients About the COVID-19 Vaccines
03/03/2021
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr Jennings breaks down the COVID-19 vaccines, and explains how to discuss them with patients.
In the first installment, Dr...
03/03/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
"F" is for Fighting for the Future of Those With Diabetic Kidney Disease
02/10/2022
Dr Jennings reviews data on finerenone, which showed efficacy in reducing kidney failure and death in patients with type 2 diabetes and advanced chronic kidney disease.
Dr Jennings reviews data on finerenone, which showed efficacy in reducing kidney failure and death in patients with type 2 diabetes and advanced chronic kidney disease.
Dr Jennings reviews data on...
02/10/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Through Thick and Thin: Is Anticoagulation Warranted in COVID-19 Infection?
11/03/2021
This week, Dr Jennings reviews data from three recently published papers regarding what symptoms and conditions make anticoagulants a viable treatment option for patients with COVID-19.
This week, Dr Jennings reviews data from three recently published papers regarding what symptoms and conditions make anticoagulants a viable treatment option for patients with COVID-19.
This week, Dr Jennings reviews...
11/03/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Evidence for the Heart-Gut Axis
08/29/2023
Dr Jennings discusses a new paper that explores the relationship between the gut microbiome and subclinical progression of atherosclerosis.
Dr Jennings discusses a new paper that explores the relationship between the gut microbiome and subclinical progression of atherosclerosis.
Dr Jennings discusses a new...
08/29/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Yet Another Diuretic for Acute Heart Failure
02/09/2023
Dr Jennings shares findings from a recent trial evaluating a thiazide for patients with acute decompensated heart failure and explores which agents may be preferred options for augmenting diuresis.
Dr Jennings shares findings from a recent trial evaluating a thiazide for patients with acute decompensated heart failure and explores which agents may be preferred options for augmenting diuresis.
Dr Jennings shares findings from...
02/09/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
The Evolving Spectrum of Ejection Fraction
09/15/2021
In the past, Talking Therapeutics has only covered virtual meetings, but in this week’s installment, Dr Jennings has his first in-person meeting recap.
In the past, Talking Therapeutics has only covered virtual meetings, but in this week’s installment, Dr Jennings has his first in-person meeting recap.
In the past, Talking...
09/15/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
A Pharmacist’s First-Hand Experience With Paxlovid
05/05/2022
Dr Jennings describes his experience taking Paxlovid after becoming infected with COVID-19 at a conference.
Dr Jennings describes his experience taking Paxlovid after becoming infected with COVID-19 at a conference.
Dr Jennings describes his...
05/05/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Still Seeking Answers for Safe Anticoagulation in Patients on Hemodialysis
12/08/2022
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study...
12/08/2022
Pharmacy Learning Network

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use